147 episodes

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.

Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.

Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

BioTalk with Rich Bendis BioHealth Innovation, Inc. (BHI)

    • Business
    • 4.7 • 11 Ratings

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.

Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.

Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

    Investing in BioHealth: Blackbird Labs Vision with CEO Matt Tremblay

    Investing in BioHealth: Blackbird Labs Vision with CEO Matt Tremblay

    What is the dynamic synergy between pioneering science and transformative industry developments? Join us in this episode of BioTalk with Rich Bendis for a thought-provoking conversation about the work of Blackbird Laboratories. Our guest, Matt Tremblay, Ph.D., Chief Executive Officer of Blackbird Laboratories, sheds light on their role in fostering innovation within the vibrant BioHealth community of Baltimore and the wider BioHealth Capital Region.

    Blackbird Laboratories recently launched with a significant $100 million founding grant from The Stephen and Renee Bisciotti Foundation. This significant investment aims to bridge the gap between academic research and industry innovation, catalyzing the development of innovative companies, groundbreaking technologies, and a thriving entrepreneurial ecosystem in Baltimore, Maryland. They provide crucial support, including capital, program management, and strategic scientific and business insights, to drive the growth of the BioHealth industry. Their team of seasoned life sciences professionals operates on a value-driven model, committed to reducing the risk of groundbreaking technology for commercialization, attracting crucial investments, nurturing start-ups, and cultivating meaningful public-private partnerships. Their vision is grounded in promoting a thriving ecosystem in Baltimore that will contribute significantly to the growth of the BioHealth sector in the region.

    In this engaging episode, we’ll delve into a diverse range of topics:
    Meet Matt and Blackbird: Learn about Matt Tremblay’s story and gain insights into Blackbird Laboratories’ mission, vision, partners, and the exceptional team and advisory board guiding their endeavors. Investment Insights: Explore Blackbird Labs’ unique investment philosophy, encompassing the stage, scale, and industries they target. Delve into their specific focus on critical science domains and gain a glimpse into the innovative projects they’ve already championed. The Baltimore and Maryland Ecosystem: Discover the pivotal role played by Baltimore and Maryland in fostering the growth of the BioHealth Capital Region. Learn about the trailblazers who inspire Blackbird Labs and their strategic efforts to support and empower the regional BioHealth community. Don’t miss this insightful episode as we discuss the promising future of BioHealth with Blackbird Laboratories leading the way. Tune in now and become an integral part of the conversation shaping the BioHealth industry’s destiny.

    • 42 min
    Breaking Barriers in Enteral Nutrition: Luminoah's Innovative MedTech with Neal Piper

    Breaking Barriers in Enteral Nutrition: Luminoah's Innovative MedTech with Neal Piper

    Are you ready to explore the transformative world of MedTech and its profound impact on healthcare? Join us in this episode of BioTalk with Rich Bendis as we dive deep into medical technology with an exceptional guest, Neal Piper, Founder & CEO of Luminoah, winner of the 8th Annual BioHealth Capital Region Crab Trap.

    Neal Piper is the visionary behind Luminoah, a cutting-edge MedTech company dedicated to enhancing the lives of enteral nutrition patients through innovative hardware and software systems. With a background steeped in healthcare, Neal's journey from Pfizer's Neuroscience Division to his role as President of the Global Health Fellows Alumni Business Network has uniquely positioned him to drive change in the industry.

    But what inspired Neal to create Luminoah? In 2019, his family received a cancer diagnosis for their 3-year-old son, leading to a new reality and a pressing need for a better nutritional feeding program. Neal recognized the challenges faced by patients and caregivers, from bulky equipment to limited data sharing with physicians. That's when Luminoah was born.

    In this compelling episode, we explore:
    The origins and mission of Luminoah, driven by a deeply personal experience. The development of the world's first truly portable, connected tube feeding system that's set to revolutionize enteral nutrition. Neal's passion for leveraging technology to transform healthcare and create positive impacts on communities worldwide. Don't miss this enlightening conversation as we journey into the heart of MedTech innovation with Neal Piper. Tune in now and be part of the conversation that's shaping the future of healthcare for enteral nutrition patients.

    • 41 min
    Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)

    Driving Cancer Research Innovation: A Conversation with Michael Weingarten, Director, SBIR Development Center at the National Cancer Institute (NCI)

    What are the latest advancements in cancer research and innovation? Join us in this episode of BioTalk with Rich Bendis as we explore the dynamic world of cancer research and technology development with our distinguished guest, Michael Weingarten, Director of the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI).

    Mr. Weingarten plays a pivotal role in leading a team of Program Directors managing the NCI's SBIR & STTR Programs, overseeing a substantial portfolio of $182 million in grants and contracts annually. These programs are at the forefront of NCI's efforts to drive innovation, fostering the development and commercialization of groundbreaking technologies and products for cancer prevention, diagnosis, and treatment.

    Explore the intersection of the BioHealth Capital Region and the NCI, understanding how collaboration and partnerships are shaping the future of cancer research and innovation. Finally, we delve into the goals for the future, highlighting the NCI's vision and commitment to advancing cancer prevention, diagnosis, and treatment through technology and innovation.

    • 41 min
    Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)

    Unlocking the Future of Stem Cell Research with MSCRF: A Conversation with Ruchika Nijhara, PhD, Executive Director of Maryland Stem Cell Research Fund (MSCRF)

    Are you curious about the world of transformative regenerative medicine and stem cell research? Are you eager to understand how Maryland champions researchers and companies in the field of stem cell and regenerative medicine? Do you want to learn more about the Maryland Stem Cell Research Fund (MSCRF)? Listen to the latest episode of BioTalk with Rich Bendis as he welcomes MSCRF Executive Director, Ruchika Nijhara, PhD.
     
    In this enlightening episode, Dr. Nijhara, a forward-thinking leader driven by her passion for advancing scientific innovation, delves into the funding mechanisms that Maryland employs to support research and development at all stages and fosters collaboration and innovation.
     
    Discover MSCRF's pivotal role in reshaping healthcare through stem cell research. Explore funding opportunities, real-world project examples, and success stories that highlight the profound impact of this research on healthcare and scientific advancements.
     
    Don't miss this captivating conversation on how MSCRF is shaping the future of scientific innovation in Maryland and beyond. Tune in now to discover more about MSCRF.
     

    • 39 min
    Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies

    Revolutionizing Autoimmune Medicine: MyMD Pharmaceuticals Innovative Therapies

    Are you interested in exploring cutting-edge autoimmune medicines? In this episode of BioTalk with Rich Bendis, we're delving deep into the world of transformative therapies with two remarkable guests, Dr. Chris Chapman and Dr. Adam Kaplin, from MyMD Pharmaceuticals.

    MyMD Pharmaceuticals is on a mission to make that a reality. Their lead clinical candidate, MYMD-1®, has the potential to reshape the entire field.

    But how does MYMD-1 work, and what sets it apart from current treatments? Join us as we unravel the science behind this revolutionary therapy and explore the potential indications and patient populations it could benefit.
    And that's not all. We also spotlight Supera-CBD, a novel synthetic cannabidiol with incredible potency and anti-inflammatory effects. How could this innovation change the landscape of chronic pain and anxiety management?

    Don't miss this episode of BioTalk with Rich Bendis as we embark on a journey into the future of autoimmune medicine with MyMD Pharmaceuticals. Tune in now and be part of the conversation.

    • 41 min
    Navigating the Future of Autoimmune Medicine: A Conversation with Dr. Theresa Podrebarac, Senior Vice President, Clinical Development at Horizon Therapeutics

    Navigating the Future of Autoimmune Medicine: A Conversation with Dr. Theresa Podrebarac, Senior Vice President, Clinical Development at Horizon Therapeutics

    How can patients help shape the future of scientific innovation? What's the vital role of the patient's voice in developing life-changing medicines? In this captivating episode, fresh off her thought-provoking appearance at the 9th Annual BioHealth Capital Region Forum, Dr. Theresa Podrebarac takes us on a journey through the dynamic landscape of autoimmune medicine.

    Dr. Podrebarac is a renowned physician scientist with a wealth of expertise in the biotech industry. As the Senior Vice President of Clinical Development at Horizon Therapeutics, she's at the forefront of bringing hope to patients with rare, autoimmune, and severe inflammatory diseases. Join us as we explore pivotal questions:
    What is Horizon Therapeutics' mission, and what are Dr. Podrebarac's primary responsibilities in this quest for life-changing medicines? How has Dr. Podrebarac's background as a rheumatologist influenced her belief in the importance of the patient's perspective in drug development? Discover Horizon's impressive journey in clinical development, with a sharp focus on autoimmune diseases. Dive into Horizon's global presence and the crucial role of its Maryland operations. What are the clinical goals that will shape the future of autoimmune medicine? Don't miss this enlightening conversation that delves into the nexus of science, patient advocacy, and innovation. Tune in now and become part of the future where patients' voices are not just heard but lead the way in shaping a brighter tomorrow. Available on all major podcasting platforms.

    Theresa Podrebarac, M.D., M.Sc., is a physician scientist with extensive development expertise in the biotech industry. At Horizon Therapeutics, Dr. Podrebarac leads the clinical development function dedicated to bringing medicines for rare, autoimmune and severe inflammatory diseases to patients. Prior to Horizon, Dr. Podrebarac served as chief medical officer at two biotech companies focusing on rare diseases.  She was also vice president, immunology clinical development at AbbVie where she helped develop approved therapies for psoriasis and rheumatoid arthritis. At Biogen, she championed the development of tools and techniques for early clinical proof of concept in diseases including scleroderma and lupus skin disease.

    Dr. Podrebarac holds a master of science in immunology from the University of Ottawa and a medical doctorate degree from Western University. She completed a postdoctoral fellowship in immunology at Harvard University.

    • 41 min

Customer Reviews

4.7 out of 5
11 Ratings

11 Ratings

laimo1bk ,

Insights into the mid Atlantic BioHealth sector

A great insiders view of biotech players in the DC region.

E Perez-Chanona ,

Great podcast about BioHealth Capital Region

Excellent resource for anyone looking to learn about the leaders, challenges and missions of the members of the BioHealth Capital Region; the biotech, academic and government research community, as well as the pharmaceutical and manufacturing industry of the D.C. metropolitan area.

Top Podcasts In Business

Ramsey Network
Money News Network
DOAC
Jocko DEFCOR Network
Sean Castrina
NPR

You Might Also Like